FDA plans ultra-fast review of three psychedelic drugs following Trump directive

WASHINGTON (AP) — The Food and Drug Administration said Friday it will offer ultra-fast review to three psychedelic drugs being developed to treat mental health conditions, including depression, the latest step by the Trump administration toward possible approval of the experimental treatments. President Donald Trump signed an executive order last weekend directing the FDA and [...]